Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 1/2011

01-01-2011 | Original Article

Mesenteric Vascular Thromboembolism in Inflammatory Bowel Disease: A Single Center Experience

Authors: Christian S. Jackson, Jonathan Fryer, Silvio Danese, Aryvdas Vanagunas, Sharon Polensky, Alan L. Buchman

Published in: Journal of Gastrointestinal Surgery | Issue 1/2011

Login to get access

Abstract

Background

Vascular thrombotic complications in inflammatory bowel disease (IBD) are well recognized, although mesenteric vascular thrombotic disease is rare.

Methods

We describe nine patients in a tertiary care center with IBD that developed thrombosis of the mesenteric arterial or venous vasculature (e.g., mesenteric thrombosis, MT).

Results

Eight subjects developed mesenteric venous thrombosis (five located in the superior mesenteric vein and three located in a branch of the portal vein) and one had a mesenteric arterial embolus, located in the splenic artery. Five subjects had Crohn's disease (CD), and four had ulcerative colitis. The one subject diagnosed with an arterial thrombosis had CD. Mean time from diagnosis of IBD to diagnosis of thrombosis was 24.6 ± 13.5 years. Five of the nine subjects developed mesenteric venous thrombosis while their IBD was clinically in remission. Seven of nine subjects were symptomatic from the development of MT, including bowel infarction that led to development of short bowel syndrome.

Conclusion

Mesenteric thrombosis is a rare complication of IBD and may develop during clinical remission, suggesting a potential role for factors other than clinically significant inflammation in its pathogenesis.
Literature
1.
go back to reference Bargen JA, Barker BN. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 1936; 58(1): 17–31. Bargen JA, Barker BN. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 1936; 58(1): 17–31.
2.
go back to reference Bernstein CN, Wajda A, Blanchard JF et al. The incidence of arterial thrombotic disease in inflammatory bowel disease: a population-based study. Clin Gastro Hepatol 2008;6(1):41–5.CrossRef Bernstein CN, Wajda A, Blanchard JF et al. The incidence of arterial thrombotic disease in inflammatory bowel disease: a population-based study. Clin Gastro Hepatol 2008;6(1):41–5.CrossRef
3.
go back to reference Miehsler W, Reinisch W, Valic E et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 2004; 53:542–548.PubMedCrossRef Miehsler W, Reinisch W, Valic E et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 2004; 53:542–548.PubMedCrossRef
4.
go back to reference Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001; 85:430–434PubMed Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001; 85:430–434PubMed
5.
go back to reference Irving P, Pasi K, Rampton D. Thrombosis and inflammatory bowel disease. Clin Gastroenterol Hepatol 2005; 3(7): 617–628.PubMedCrossRef Irving P, Pasi K, Rampton D. Thrombosis and inflammatory bowel disease. Clin Gastroenterol Hepatol 2005; 3(7): 617–628.PubMedCrossRef
6.
go back to reference Solem CA, Loftus EV, Tremaine W, et al. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 2004; 99(1): 97–101PubMedCrossRef Solem CA, Loftus EV, Tremaine W, et al. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 2004; 99(1): 97–101PubMedCrossRef
7.
go back to reference Irving PM, Alstead EM, Greaves RR et al. Acute mesenteric infarction: an important cause of abdominal pain in ulcerative colitis. Eur J Gastroenterol Hepatol 2005;17:1429–32PubMedCrossRef Irving PM, Alstead EM, Greaves RR et al. Acute mesenteric infarction: an important cause of abdominal pain in ulcerative colitis. Eur J Gastroenterol Hepatol 2005;17:1429–32PubMedCrossRef
8.
go back to reference Ha C, Magowan S, Accortt N, et al. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol 2009; 104:1445–51.PubMedCrossRef Ha C, Magowan S, Accortt N, et al. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol 2009; 104:1445–51.PubMedCrossRef
9.
go back to reference Kaleya RN, Boley SJ. Aggressive approach to acute mesenteric ischemia. Surg Clin North Am 1992; 35(6): 613–23. Kaleya RN, Boley SJ. Aggressive approach to acute mesenteric ischemia. Surg Clin North Am 1992; 35(6): 613–23.
10.
go back to reference Danese S, Papa A, Saibeni S, et al. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol 2007; 102:174–86.PubMedCrossRef Danese S, Papa A, Saibeni S, et al. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol 2007; 102:174–86.PubMedCrossRef
11.
go back to reference Geelkerken RH., van Bockel JH Mesenteric vascular disease : a review of diagnostic methods and therapies. Cardiovascular Surgery 1995; 3(3):247–260.PubMedCrossRef Geelkerken RH., van Bockel JH Mesenteric vascular disease : a review of diagnostic methods and therapies. Cardiovascular Surgery 1995; 3(3):247–260.PubMedCrossRef
12.
go back to reference Danese S, Katz JA, Saibeni S, et al. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 2004; 52:1435–41.CrossRef Danese S, Katz JA, Saibeni S, et al. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 2004; 52:1435–41.CrossRef
13.
go back to reference Danese S, Sans M, Scaldaferri F, et al. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease. J Immunol 2006; 176:2617–24.PubMed Danese S, Sans M, Scaldaferri F, et al. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease. J Immunol 2006; 176:2617–24.PubMed
14.
go back to reference Talbot RJ, Heppell J, Dozois R, et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986;61(2):140–145.PubMed Talbot RJ, Heppell J, Dozois R, et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986;61(2):140–145.PubMed
15.
go back to reference Irving P, Macey MG, Feakins R, et al. Platelet-leucocyte aggregates form i inthe mesenteric vasculature in patients with ulcerative colitis. Eur I Gastroenterol and Hepatol 2008,20:283–289PubMedCrossRef Irving P, Macey MG, Feakins R, et al. Platelet-leucocyte aggregates form i inthe mesenteric vasculature in patients with ulcerative colitis. Eur I Gastroenterol and Hepatol 2008,20:283–289PubMedCrossRef
16.
go back to reference Oldenburg B, Fijnheer R, van der Griend RR, et al. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications? Am J Gastroenterol 2000; 95:2825–30.PubMedCrossRef Oldenburg B, Fijnheer R, van der Griend RR, et al. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications? Am J Gastroenterol 2000; 95:2825–30.PubMedCrossRef
17.
go back to reference Hatoum OA, Spinelli KS, Abu-Hajir M. et al. Mesenteric venous thrombosis in nflammatory bowel disease. J Clin Gastroenterol 2005; 39:27–31PubMed Hatoum OA, Spinelli KS, Abu-Hajir M. et al. Mesenteric venous thrombosis in nflammatory bowel disease. J Clin Gastroenterol 2005; 39:27–31PubMed
18.
go back to reference Fichera A, Cicchiello LA, Mendelson DS, et al. Superior mesenteric vein thrombosis after colectomy for inflammatory bowel disease: a not uncommon cause of postoperative acute abdominal pain. Dis Colon Rectum, 2003; 46:643–648.PubMedCrossRef Fichera A, Cicchiello LA, Mendelson DS, et al. Superior mesenteric vein thrombosis after colectomy for inflammatory bowel disease: a not uncommon cause of postoperative acute abdominal pain. Dis Colon Rectum, 2003; 46:643–648.PubMedCrossRef
19.
go back to reference Webberly MJ, Hart MT, Mehlikian V. Thromboembolism in inflammatory bowel disease: role of platelets. Gut. 1993; 34(2): 247–51CrossRef Webberly MJ, Hart MT, Mehlikian V. Thromboembolism in inflammatory bowel disease: role of platelets. Gut. 1993; 34(2): 247–51CrossRef
20.
go back to reference Collins CE, Rampton DS, Rogers J et al. Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1997; 9: 1213–17PubMed Collins CE, Rampton DS, Rogers J et al. Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1997; 9: 1213–17PubMed
21.
go back to reference Liu Z, Colpaert S, D'Haens GR et al. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production. J Immunol 1999; 163:4049–4057PubMed Liu Z, Colpaert S, D'Haens GR et al. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production. J Immunol 1999; 163:4049–4057PubMed
22.
go back to reference Battaglia E, Biacene L, Resegotti A et al. Expression of CD40 and its ligand CD 40L, in intestinal lesions of Crohn's disease. Am J Gastroenterol 1999; 94:3279–3284PubMedCrossRef Battaglia E, Biacene L, Resegotti A et al. Expression of CD40 and its ligand CD 40L, in intestinal lesions of Crohn's disease. Am J Gastroenterol 1999; 94:3279–3284PubMedCrossRef
23.
go back to reference Vogel JD, West GA, Danese S et al. CD40 mediated immune-non immune cells interactions induce mucosal fibroblast chemokines leading to T-cell transmigration. Gastroenterlogy 2004;126:63–80CrossRef Vogel JD, West GA, Danese S et al. CD40 mediated immune-non immune cells interactions induce mucosal fibroblast chemokines leading to T-cell transmigration. Gastroenterlogy 2004;126:63–80CrossRef
24.
go back to reference Danese S, de la Motte C, Sturm A, et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 2003; 124:1249–64.PubMedCrossRef Danese S, de la Motte C, Sturm A, et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 2003; 124:1249–64.PubMedCrossRef
Metadata
Title
Mesenteric Vascular Thromboembolism in Inflammatory Bowel Disease: A Single Center Experience
Authors
Christian S. Jackson
Jonathan Fryer
Silvio Danese
Aryvdas Vanagunas
Sharon Polensky
Alan L. Buchman
Publication date
01-01-2011
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 1/2011
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-010-1336-2

Other articles of this Issue 1/2011

Journal of Gastrointestinal Surgery 1/2011 Go to the issue